No price history available.
Key financial summary
Financials in MYR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | MYRm | 1,050 | 1,243 | 1,601 | 1,821 | 1,936 | 1,898 | N/A | N/A |
| Operating profit | MYRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | MYRm | 192 | 243 | 275 | 311 | 329 | 272 | N/A | N/A |
| EPS reported | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | MYRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | MYRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | MYRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in MYR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
DXN Holdings Bhd. functions as an investment holding entity, primarily involved in the production and direct distribution of a comprehensive range of health supplements and various other consumer products. The company's activities encompass the manufacturing, processing, marketing, sale, and distribution of health foods, non-alcoholic drinks, dietary supplements, traditional medicines, cosmetics, personal care items, skincare products, spirulina and cordyceps cereals, confectionery, and biscuits. Beyond its core product lines, DXN engages in a multitude of additional ventures. These include providing information technology advisory and consulting services, trading computer hardware and software, and dealing in construction materials. The company also oversees plantations for rubber trees and cash crops, cultivates, processes, and trades mushrooms and spirulina, and processes virgin palm oil. Its operations extend to agricultural and forest plantations, as well as the cultivation, research, development, and processing of tea, alongside its wholesale and retail distribution. Furthermore, DXN trades in chemical materials and various horticultural crops. The company is deeply invested in research and development, conducting experimental work in biotechnology, biochemical, and agricultural products, and performing analytical laboratory tests for pharmaceutical and biological items. It also practices aquaponics farming, cultivation, and processing, provides marketing consultancy services, engages in general trading, and offers ganotherapy consultation and treatment. Additionally, DXN Holdings Bhd. operates a hospitality and tourism portfolio, which includes cafes, a glamping resort, a tourism village complex, and a marine sanctuary, alongside property management. The company maintains a significant global presence, with operations spanning South America, Malaysia, other parts of Asia, North America, Africa, Europe, the Middle East, and Oceania. Founded in 1993 and headquartered in Alor Setar, Malaysia, DXN Holdings Bhd. operates as a subsidiary of LSJ Global Sdn. Bhd.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
DXN Holdings Bhd. (5318.KL)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
DXN Holdings Bhd. functions as an investment holding entity, primarily involved in the production and direct distribution of a comprehensive range of health supplements and various other consumer products. The company's activities encompass the manufacturing, processing, marketing, sale, and distribution of health foods, non-alcoholic drinks, dietary supplements, traditional medicines, cosmetics, personal care items, skincare products, spirulina and cordyceps cereals, confectionery, and biscuits. Beyond its core product lines, DXN engages in a multitude of additional ventures. These include providing information technology advisory and consulting services, trading computer hardware and software, and dealing in construction materials. The company also oversees plantations for rubber trees and cash crops, cultivates, processes, and trades mushrooms and spirulina, and processes virgin palm oil. Its operations extend to agricultural and forest plantations, as well as the cultivation, research, development, and processing of tea, alongside its wholesale and retail distribution. Furthermore, DXN trades in chemical materials and various horticultural crops. The company is deeply invested in research and development, conducting experimental work in biotechnology, biochemical, and agricultural products, and performing analytical laboratory tests for pharmaceutical and biological items. It also practices aquaponics farming, cultivation, and processing, provides marketing consultancy services, engages in general trading, and offers ganotherapy consultation and treatment. Additionally, DXN Holdings Bhd. operates a hospitality and tourism portfolio, which includes cafes, a glamping resort, a tourism village complex, and a marine sanctuary, alongside property management. The company maintains a significant global presence, with operations spanning South America, Malaysia, other parts of Asia, North America, Africa, Europe, the Middle East, and Oceania. Founded in 1993 and headquartered in Alor Setar, Malaysia, DXN Holdings Bhd. operates as a subsidiary of LSJ Global Sdn. Bhd.
